Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Summary of Product Characteristics last updated on the eMC: 30/05/2008
SPC Vibramycin 50 CAPSULES

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/05/2008 and displayed until Current
Reasons for adding or updating:
  • Change to joint SPC covering all presentations
Date of revision of text on the SPC:   01-May-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

We are replacing the joint SPC for Vibramcyin D 100 mg and 50 mg with two seperate SPCs.  All other products currently associated with these SPCs will be retired.  We are going to submit the SPC for 100 mg as a new SPC. 
If you have any further questions please feel free to call.
Updated on 20/09/2006 and displayed until 30/05/2008
Reasons for adding or updating:
  • Change to joint SPC covering all presentations
Date of revision of text on the SPC:   09/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

 
Removal of Vibramycin Capsules 100 mg from the joint SPC.
Updated on 26/10/2004 and displayed until 20/09/2006
Reasons for adding or updating:
  • Change to section 3 - pharmaceutical form
  • Change to section 6.1 - List of Excipients
Updated on 07/11/2002 and displayed until 26/10/2004
Reasons for adding or updating:
  • Addition of Legal Category
Updated on 06/11/2002 and displayed until 07/11/2002
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
Updated on 09/10/2001 and displayed until 06/11/2002
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Updated on 24/08/2001 and displayed until 09/10/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 07/09/2000 and displayed until 24/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 07/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   doxycycline